https://www.selleckchem.com/pr....oducts/i-bet151-gsk1
Research has shown that many patients with type 2 diabetes (T2D) are not adherent to their medication regimen. To examine the association between adherence to insulin therapy and all-cause health care costs for patients with T2D. This study used the IQVIA PharMetrics Plus Linkable to Ambulatory Electronic Medical Record data from January 1, 2012, through September 30, 2017. Patients were included if they were identified with T2D and initiated therapy on basal insulin (BAS) or basal-bolus (BAS-BOL) combination at any time fr
Like
Comment
Share
